Cautious Guidance Offsets Solid Q4 for CeriBell, Inc. (CBLL), Says Canaccord

CeriBell, Inc. (NASDAQ:CBLL) is among the 12 Most Promising Small-Cap Stocks According to Wall Street Analysts.

Cautious Guidance Offsets Solid Q4 for CeriBell, Inc. (CBLL), Says Canaccord

CeriBell, Inc. (NASDAQ:CBLL) secures the twelfth place on our list of most promising stocks.

TheFly reported on February 25 that Canaccord reduced its price target for CBLL from $30 to $28 and maintained a Buy rating on the stock. The firm pointed to a strong fourth-quarter earnings beat for the company and noted that management issued cautious guidance despite several upcoming growth drivers.

CeriBell, Inc. (NASDAQ:CBLL) presented results for the fourth quarter and the entire year of 2025 earlier on February 24. The company reported its fourth-quarter sales of $24.8 million, which is up 34% from the previous year. The company said that this growth was fueled by an increase in both new and existing accounts. Subscription sales rose 37% to $6.0 million, while product revenue increased 33% to $18.8 million. The quarter ended with a gross profit of $21.6 million and a gross margin of 87%. At $0.36 per share, the corporation reported a net loss of $13.5 million.

The company’s total income for the year was $89.1 million, up 36% from 2024. This amount included $21.7 million from subscriptions and $67.3 million from products. 88% was the full-year gross margin. With 647 active accounts and $159.3 million in cash, cash equivalents, and marketable securities at the end of 2025, CeriBell, Inc. (NASDAQ:CBLL). A number of FDA clearances were also obtained by the company, which anticipates $111 million to $115 million in sales in 2026.

CeriBell, Inc. (NASDAQ:CBLL) is a medical technology company focused on rapid EEG solutions for neurological care. Its portable brain-monitoring systems use AI-powered analytics to help hospitals quickly detect seizures and improve timely diagnosis and treatment in critical care settings.

While we acknowledge the potential of CBLL as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than CBLL and that has a 100x upside potential, check out our report about the cheapest AI stock.

READ NEXT: 14 Best GARP Stocks to Buy According to Analysts and 14 Best Affordable Dividend Stocks to Buy According to Analysts.

Disclosure: None. Follow Insider Monkey on Google News.